129 related articles for article (PubMed ID: 18497072)
1. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.
Jacobson HI; Lemanski N; Narendran A; Agarwal A; Bennett JA; Andersen TT
Adv Exp Med Biol; 2008; 617():477-84. PubMed ID: 18497072
[TBL] [Abstract][Full Text] [Related]
2. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
Jacobson HI; Lemanski N; Agarwal A; Narendran A; Turner KE; Bennett JA; Andersen TT
Cancer Prev Res (Phila); 2010 Feb; 3(2):212-20. PubMed ID: 19934340
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
Yuri T; Lai YC; Yoshizawa K; Tsubura A
In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Lukanova A; Andersson R; Wulff M; Zeleniuch-Jacquotte A; Grankvist K; Dossus L; Afanasyeva Y; Johansson R; Arslan AA; Lenner P; Wadell G; Hallmans G; Toniolo P; Lundin E
Am J Epidemiol; 2008 Dec; 168(11):1284-91. PubMed ID: 18936438
[TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin suppresses human breast cancer cell growth directly via p53-mediated mitochondrial apoptotic pathway and indirectly via ovarian steroid secretion.
Yuri T; Kinoshita Y; Emoto Y; Yoshizawa K; Tsubura A
Anticancer Res; 2014 Mar; 34(3):1347-54. PubMed ID: 24596382
[TBL] [Abstract][Full Text] [Related]
7. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
8. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
9. Hormonal prevention of breast cancer: significance of promotional environment.
Lakshmanaswamy R; Guzman RC; Nandi S
Adv Exp Med Biol; 2008; 617():469-75. PubMed ID: 18497071
[TBL] [Abstract][Full Text] [Related]
10. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
11. hCG, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy.
Grosskinsky CM; Hage ML; Tyrey L; Christakos AC; Hughes CL
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):705-9. PubMed ID: 7682316
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of breast cancer by hormone-induced differentiation.
Russo IH; Russo J
Recent Results Cancer Res; 2007; 174():111-30. PubMed ID: 17302191
[TBL] [Abstract][Full Text] [Related]
13. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Vakharia D; Mizejewski GJ
Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
[TBL] [Abstract][Full Text] [Related]
14. Estrogen induction of progestophilins in rat estrogen-sensitive cells grown in media supplemented with sera from castrated rats and from rats bearing an alpha-fetoprotein-secreting hepatoma.
Soto AM; Lee H; Siiteri PK; Murai JT; Sonnenschein C
Exp Cell Res; 1984 Feb; 150(2):390-9. PubMed ID: 6198194
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
16. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol.
O'Brien JE; Dvorin E; Drugan A; Johnson MP; Yaron Y; Evans MI
Obstet Gynecol; 1997 Mar; 89(3):355-8. PubMed ID: 9052584
[TBL] [Abstract][Full Text] [Related]
17. Purified human alpha fetoprotein inhibits growth factor-stimulated estradiol production by porcine granulosa cells in monolayer culture.
Keel BA; Eddy KB; Cho S; Gangrade BK; May JV
Endocrinology; 1992 Jun; 130(6):3715-7. PubMed ID: 1375908
[TBL] [Abstract][Full Text] [Related]
18. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
Sell S; Becker FF; Leffert HL; Watabe L
Cancer Res; 1976 Nov; 36(11 Pt. 2):4239-49. PubMed ID: 61804
[TBL] [Abstract][Full Text] [Related]
19. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
20. Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.
Nair HB; Santhamma B; Krishnegowda NK; Dileep KV; Nickisch KJ
PLoS One; 2016; 11(3):e0151182. PubMed ID: 27011208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
